187043EGP
- Active ingredient
- ocrelizumab
- Strength
- 300mg/10ml
- Form
- vial
- Manufacturer
- f.hoffman la roche
- Route
- injection
Uses
Used for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Do not use if
Active hepatitis B infection or history of life-threatening infusion reaction to ocrelizumab.
Side effects
Infusion reactions, infections, reduced immunoglobulins, and injection-related complications may occur.
Warnings
Serious infections and progressive multifocal leukoencephalopathy may occur. Monitor patients carefully.
How it works
CD20-directed monoclonal antibody that depletes B lymphocytes.
Storage
Store refrigerated at 2°C to 8°C. Protect from light. Do not freeze or shake.
